₹910.15
+19.65 (+2.21%)
As of 28 Aug 2026, Remus Pharmaceuticals Ltd share price is ₹910.15. The stock opened at ₹910.15 and had closed at ₹890.50 the previous day. Over the last 52 weeks, the stock has recorded a low of ₹580.00 and a high of ₹987.50. In terms of performance, Remus Pharmaceuticals Ltd share price has increased by 36.05% over the past six months and has increased by 2.03% over the last year.
REMUS Charts
Remus Pharmaceuticals Ltd Overview
Market cap₹1,073 Crs
Volume5,200
Prev. Close₹890.50
Year range₹580.00 - ₹987.50
Total Value₹47,32,780.00
ISININE0O5T01011
About REMUS
Remus Pharmaceuticals is engaged in marketing and distribution of pharmaceuticals products and allied products.
Remus Pharmaceuticals Ltd Historical Performance
1 Month Return26.23%
6 Month Return36.05%
3 Year Return61.55%
3 Month Return27.73%
1 Year Return-1.99%
5 Year Return-
Remus Pharmaceuticals Ltd Fundamental Analysis
ROCE(TTM)10.19%
P/E Ratio (TTM)43.40
P/B Ratio3.29
Debt to Equity0.02
ROE7.59%
EPS (TTM)20.97
Dividend Yield0.05%
Book Value276.40
Profit Margin0.00%
Operating Margin0.00%
Remus Pharmaceuticals Ltd Financials
| Indicator | No Data Available |
|---|---|
| Revenue | |
| EBITDA | |
| Net Profit | |
| EPS |
Remus Pharmaceuticals Ltd Technical Analysis
| Indicator | Value |
|---|---|
| RSI | 58.49 |
| MACD | 44.42 |
| 20-Day SMA | 852.47 |
Remus Pharmaceuticals Ltd Corporate Actions
| Corporate Action | Ex Date | Record Date |
|---|---|---|
| No forthcoming board meetings available. | ||
Remus Pharmaceuticals Ltd Peer Comparison
| Company | Price | M.Cap (Cr) | P/E (TTM) | ROE (TTM) |
|---|---|---|---|---|
| Sun Pharmaceutical Industries LtdSUNPHARMA | ₹1,913.30+0.73% | ₹4,19,727.66 | 38.32 | 13.74% |
| Divis Laboratories LtdDIVISLAB | ₹9,060.00+0.39% | ₹1,67,235.91 | 67.46 | 15.32% |
| Torrent Pharmaceuticals LtdTORNTPHARM | ₹4,999.00+2.23% | ₹1,46,951.32 | 64.68 | 25.49% |
Disclaimer
The information provided on this page is for informational purposes only and should not be construed as investment advice, recommendation, or solicitation to buy or sell any securities or financial pr...
Frequently Asked Questions
- The share price of Remus Pharmaceuticals Ltd today is ₹910.15 on NSE and ₹910.15 on BSE.
- The 52-week high of Remus Pharmaceuticals Ltd is ₹987.50, while the 52-week low is ₹580.00.
- The current market capitalisation of Remus Pharmaceuticals Ltd is approximately ₹1,073 crore.
- The P/E (Price-to-Earnings) ratio of Remus Pharmaceuticals Ltd is 18.28. The ratio may vary with changes in the share price and earnings.
- The P/B (Price-to-Book) ratio of Remus Pharmaceuticals Ltd is 2.74. It compares the company’s market value with its book value and can provide an indication of how the market values the company relative to its net assets.
- To invest in Remus Pharmaceuticals Ltd shares,
• Open a Demat and trading account with a registered broker
• Add funds to your account
• Search for Remus Pharmaceuticals Ltd on the trading platform
• Place a buy order
• Track your investments - Over the past 3 years, Remus Pharmaceuticals Ltd has delivered a return of approximately 61.55%. This return is based on the change in the share price over the specified period and may differ depending on the measurement date. Past performance does not guarantee future returns.
- The shareholding pattern of Remus Pharmaceuticals Ltd comprises different categories of shareholders. As of Mar 2026, the shareholding is approximately 70.95% promoters, 5.28% FIIs, 0.83% DIIs, and 18.50% public shareholders.
Download TradeMobi App
- Real-Time Market Data
- Advanced Trading Tools
- Expert-Backed Research
